Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.20.2
Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Statements of Operations        
Revenue, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Grant revenue $ 6,515   $ 6,515 $ 0
Cost, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Cost of grant revenue $ 6,515   $ 6,515  
Operating expenses:        
Research and development 316,325 $ 335,752 666,989 $ 553,968
General and administrative 515,878 580,663 1,095,648 1,049,053
Total operating expenses 832,203 916,415 1,762,637 1,603,021
Loss from continuing operations before interest (832,203) (916,415) (1,762,637) (1,603,021)
Interest (income) expense, net 1,055 (6,809) 1,122 309
Loss from continuing operations (833,258) (909,606) (1,763,759) (1,603,330)
Loss from discontinued operations   (342,076)   (689,251)
Net loss $ (833,258) $ (1,251,682) $ (1,763,759) $ (2,292,581)
Loss from continuing operations per share - basic and fully diluted (in dollars per share) $ (0.28) $ (0.62) $ (0.59) $ (1.10)
Loss from discontinued operations per share - basic and fully diluted (in dollars per share)   (0.23)   (0.48)
Net loss per share - basic and fully diluted $ (0.28) $ (0.85) $ (0.59) $ (1.58)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 2,998,350 1,474,001 2,983,372 1,453,648